SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-044684
Filing Date
2020-09-25
Accepted
2020-09-25 17:06:14
Documents
10
Period of Report
2020-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20200924.htm   iXBRL 8-K 37161
  Complete submission text file 0001564590-20-044684.txt   166871

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srpt-20200924.xsd EX-101.SCH 5820
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20200924_lab.xml EX-101.LAB 19493
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20200924_pre.xml EX-101.PRE 11663
5 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20200924_htm.xml XML 3558
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 201200871
SIC: 2834 Pharmaceutical Preparations